Delivery Order SPE2DB20D7066-SPE2DB25FC1ZF

Award Date 1/7/25
Potential Completion Date 1/8/25
Potential Value $6.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,660.04, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Albuterol HFA 90 MCG Inhalers, a critical medical commodity used in the treatment of respiratory conditions. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued...
This federal contract award is for the delivery of Albuterol HFA 90 MCG Inhalers, a critical pharmaceutical product used in the treatment of respiratory conditions. The $1,268.74 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen, valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,556,138,924 units of Albuterol HFA 90 MCG Inhaler 8.5GM. The $8,560.86 firm fixed-price delivery order was placed under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. (doing business as Amerisourcebergen) holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $10,120.20, is for the delivery of Albuterol HFA 90 MCG inhalers over the period ending on October 8, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a major defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $7,666.56 firm-fixed-price delivery order is for the supply of 4,565,808,616 units of Albuterol HFA 90 MCG Inhalation Aerosol, a critical respiratory medication. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that Amerisourcebergen holds with the DLA...
This federal contract award, valued at $1,991.16, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of Albuterol HFA 90 MCG Inhalers, a critical pharmaceutical product used to treat respiratory conditions. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide 4,561,489,105 units of the Albuterol HFA 90 MCG Inhaler 8.5GM. The award, valued at $1,656.96, is a firm fixed-price delivery order contract with a completion date of July 14, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award, valued at $8,927.41, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of Albuterol HFA 90 MCG Inhalers, a critical medication used for the treatment of respiratory conditions. This contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,189.10 firm fixed-price delivery order is for the supply of Albuterol HFA 90 MCG inhalers, with a completion date of November 6, 2024. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a prime vehicle for...
This federal contract award, valued at $1,853.49, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Albuterol HFA 90 MCG Inhaler 8.5GM, a critical pharmaceutical product used for respiratory care. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through...
  • SPE2DB20D7066
    Indefinite Delivery Contract
  • SPE2DB20D7066-SPE2DB25FC1ZF
    Delivery Order

This federal contract award, valued at $6,609.09, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of albuterol HFA 90 mcg inhalers, a critical medical commodity for federal healthcare programs.

The award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. There is no set-aside designation for this contract.

Generated 4/8/25, 9:53 AM